TreeWAS – Variant ID: rs17027130

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
M19.99 Arthrosis, unspecified (Site unspecified)	0.000	0.982	0.018
C67.9 Bladder, unspecified	0.000	0.985	0.015
C67 Malignant neoplasm of bladder	0.000	0.988	0.012
M19.9 Arthrosis, unspecified	0.000	0.989	0.011
C80.0 Malignant neoplasm, primary site unknown, so stated	0.011	0.989	0.000
C67.2 Lateral wall of bladder	0.000	0.989	0.011
M19.94 Arthrosis, unspecified (Hand)	0.000	0.990	0.010
K74.6 Other and unspecified cirrhosis of liver	0.010	0.990	0.000
C80.9 Malignant neoplasm, unspecified	0.010	0.990	0.000
T42.4 Benzodiazepines	0.000	0.990	0.010
M19.95 Arthrosis, unspecified (Pelvic region and thigh)	0.000	0.990	0.010
M19.90 Arthrosis, unspecified (Multiple sites)	0.000	0.990	0.010
K74 Fibrosis and cirrhosis of liver	0.009	0.991	0.000
C80 Malignant neoplasm without specification of site	0.009	0.991	0.000
M19.92 Arthrosis, unspecified (Upper arm)	0.000	0.991	0.009
K74.3 Primary biliary cirrhosis	0.009	0.991	0.000
C67.5 Bladder neck	0.000	0.991	0.009
C67.6 Ureteric orifice	0.000	0.991	0.009
C67.3 Anterior wall of bladder	0.000	0.991	0.009
C67.8 Overlapping lesion of bladder	0.000	0.991	0.008
C67.7 Urachus	0.000	0.991	0.008
C67.0 Trigone of bladder	0.000	0.991	0.008
C67.4 Posterior wall of bladder	0.000	0.992	0.008
C67.1 Dome of bladder	0.000	0.992	0.008
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.992	0.008
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.008	0.992	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.992	0.008
M19.91 Arthrosis, unspecified (Shoulder region)	0.000	0.992	0.008
M19.98 Arthrosis, unspecified (Other)	0.000	0.993	0.007
M19.93 Arthrosis, unspecified (Forearm)	0.000	0.993	0.007
K70-K77 Diseases of liver	0.007	0.993	0.000
K74.5 Biliary cirrhosis, unspecified	0.007	0.993	0.000
K74.4 Secondary biliary cirrhosis	0.007	0.993	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.007	0.993	0.000
K74.1 Hepatic sclerosis	0.007	0.993	0.000
K76 Other diseases of liver	0.007	0.993	0.000
M19.96 Arthrosis, unspecified-Lower leg	0.000	0.993	0.007
D18.0 Haemangioma, any site	0.007	0.993	0.000
K76.8 Other specified diseases of liver	0.007	0.993	0.000
K74.0 Hepatic fibrosis	0.006	0.994	0.000
K70 Alcoholic liver disease	0.006	0.994	0.000
M19.97 Arthrosis, unspecified (Ankle and foot)	0.000	0.994	0.006
M47.99 Spondylosis, unspecified (Site unspecified)	0.006	0.994	0.000
K73 Chronic hepatitis, not elsewhere classified	0.006	0.994	0.000
K76.9 Liver disease, unspecified	0.006	0.994	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.994	0.006
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.994	0.006
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.994	0.006
T42.3 Barbiturates	0.000	0.994	0.006
T42.2 Succinimides and oxazolidinediones	0.000	0.994	0.006
T42.0 Hydantoin derivatives	0.000	0.994	0.006
T42.1 Iminostilbenes	0.000	0.994	0.006
K76.6 Portal hypertension	0.006	0.994	0.000
K70.4 Alcoholic hepatic failure	0.006	0.994	0.000
K76.7 Hepatorenal syndrome	0.005	0.995	0.000
K77 Liver disorders in diseases classified elsewhere	0.005	0.995	0.000
K71 Toxic liver disease	0.005	0.995	0.000
K76.5 Hepatic veno-occlusive disease	0.005	0.995	0.000
K76.4 Peliosis hepatis	0.005	0.995	0.000
K76.3 Infarction of liver	0.005	0.995	0.000
K76.2 Central haemorrhagic necrosis of liver	0.005	0.995	0.000
K76.1 Chronic passive congestion of liver	0.005	0.995	0.000
K73.9 Chronic hepatitis, unspecified	0.005	0.995	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.005	0.995	0.000
K70.1 Alcoholic hepatitis	0.005	0.995	0.000
Z85.5 Personal history of malignant neoplasm of urinary tract	0.000	0.995	0.005
K70.0 Alcoholic fatty liver	0.005	0.995	0.000
K70.3 Alcoholic cirrhosis of liver	0.005	0.995	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.005	0.995	0.000
K75 Other inflammatory liver diseases	0.005	0.995	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.005	0.995	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.005	0.995	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.005	0.995	0.000
N97.9 Female infertility, unspecified	0.005	0.995	0.000
R20.2 Paraesthesia of skin	0.000	0.995	0.005
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.000	0.995	0.005
Z86.1 Personal history of infectious and parasitic diseases	0.000	0.995	0.005
K70.9 Alcoholic liver disease, unspecified	0.004	0.996	0.000
K72 Hepatic failure, not elsewhere classified	0.004	0.996	0.000
C64-C68 Malignant neoplasms of urinary tract	0.000	0.996	0.004
K71.9 Toxic liver disease, unspecified	0.004	0.996	0.000
K71.8 Toxic liver disease with other disorders of liver	0.004	0.996	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.004	0.996	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.004	0.996	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.004	0.996	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.004	0.996	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.004	0.996	0.000
K71.2 Toxic liver disease with acute hepatitis	0.004	0.996	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.004	0.996	0.000
K71.0 Toxic liver disease with cholestasis	0.004	0.996	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.004	0.996	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
K75.9 Inflammatory liver disease, unspecified	0.004	0.996	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.004	0.996	0.000
K75.4 Autoimmune hepatitis	0.004	0.996	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.003	0.996	0.000
K75.2 Nonspecific reactive hepatitis	0.003	0.996	0.000
K75.1 Phlebitis of portal vein	0.003	0.996	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.003	0.996	0.000
J33.0 Polyp of nasal cavity	0.004	0.996	0.000
C66 Malignant neoplasm of ureter	0.000	0.996	0.003
C65 Malignant neoplasm of renal pelvis	0.000	0.997	0.003
K72.1 Chronic hepatic failure	0.003	0.997	0.000
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.003	0.997	0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.000	0.997	0.003
K72.0 Acute and subacute hepatic failure	0.003	0.997	0.000
K65.9 Peritonitis, unspecified	0.000	0.997	0.003
C68 Malignant neoplasm of other and unspecified urinary organs	0.000	0.997	0.003
K75.0 Abscess of liver	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
D18 Haemangioma and lymphangioma, any site	0.003	0.997	0.000
I73.0 Raynaud's syndrome	0.003	0.997	0.000
K65.0 Acute peritonitis	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.003
M47.9 Spondylosis, unspecified	0.003	0.997	0.000
N20.0 Calculus of kidney	0.000	0.997	0.003
S22.40 Multiple fractures of ribs (closed)	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
M19 Other arthrosis	0.000	0.997	0.003
K75.8 Other specified inflammatory liver diseases	0.002	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
C68.9 Urinary organ, unspecified	0.000	0.997	0.002
C68.8 Overlapping lesion of urinary organs	0.000	0.997	0.002
C68.1 Paraurethral glands	0.000	0.997	0.002
C68.0 Urethra	0.000	0.997	0.002
D18.1 Lymphangioma, any site	0.003	0.997	0.000
M88.9 Paget's disease of bone, unspecified	0.003	0.997	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.000	0.997	0.003
K72.9 Hepatic failure, unspecified	0.002	0.997	0.000
M21.3 Wrist or foot drop (acquired)	0.003	0.997	0.000
M47.94 Spondylosis, unspecified (Thoracic region)	0.002	0.997	0.000
L98.8 Other specified disorders of skin and subcutaneous tissue	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.002
K65 Peritonitis	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.002
T36 Poisoning by systemic antibiotics	0.000	0.997	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.002
T39.0 Salicylates	0.000	0.998	0.002
K76.0 Fatty (change of) liver, not elsewhere classified	0.002	0.998	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.002	0.998	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
N97 Female infertility	0.002	0.998	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.002	0.998	0.000
M65.4 Radial styloid tenosynovitis [de Quervain]	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
N97.8 Female infertility of other origin	0.002	0.998	0.000
M19.8 Other specified arthrosis	0.000	0.998	0.002
S22.4 Multiple fractures of ribs	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
O82.0 Delivery by elective Caesarean section	0.002	0.998	0.000
Z91.6 Personal history of other physical trauma	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
M88.98 Paget's disease of bone, unspecified (Other)	0.002	0.998	0.000
M88.97 Paget's disease of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
M88.96 Paget's disease of bone, unspecified (Lower leg)	0.002	0.998	0.000
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M88.94 Paget's disease of bone, unspecified (Hand)	0.002	0.998	0.000
M88.93 Paget's disease of bone, unspecified (Forearm)	0.002	0.998	0.000
M88.92 Paget's disease of bone, unspecified (Upper arm)	0.002	0.998	0.000
M88.91 Paget's disease of bone, unspecified (Shoulder region)	0.002	0.998	0.000
M21.39 Wrist or foot drop (acquired)-Site unspec	0.002	0.998	0.000
M21.38 Wrist or foot drop (acquired)-Other	0.002	0.998	0.000
M21.36 Wrist or foot drop (acquired)-Lower leg	0.002	0.998	0.000
M21.35 Wrist or foot drop (acquired)-Pelvic/thigh	0.002	0.998	0.000
M21.34 Wrist or foot drop (acquired) (Hand)	0.002	0.998	0.000
M21.33 Wrist or foot drop (acquired) (Forearm)	0.002	0.998	0.000
M21.32 Wrist or foot drop (acquired)-Upper arm	0.002	0.998	0.000
M21.31 Wrist or foot drop (acquired)-Shldr region	0.002	0.998	0.000
M21.30 Wrist or foot drop (acquired) (Multiple sites)	0.002	0.998	0.000
Q61.2 Polycystic kidney, adult type	0.000	0.998	0.002
D68.2 Hereditary deficiency of other clotting factors	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
D63.0 Anaemia in neoplastic disease	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
M19.1 Posttraumatic arthrosis of other joints	0.000	0.998	0.002
Z85.4 Personal history of malignant neoplasm of genital organs	0.000	0.998	0.002
C64 Malignant neoplasm of kidney, except renal pelvis	0.000	0.998	0.002
M19.2 Other secondary arthrosis	0.000	0.998	0.002
N97.4 Female infertility associated with male factors	0.002	0.998	0.000
N97.3 Female infertility of cervical origin	0.002	0.998	0.000
N97.2 Female infertility of uterine origin	0.002	0.998	0.000
N97.0 Female infertility associated with anovulation	0.002	0.998	0.000
R49.0 Dysphonia	0.002	0.998	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
M65.49 Radial styloid tenosynovitis [de Quervain]-Site unspec	0.002	0.998	0.000
M65.48 Radial styloid tenosynovitis [de Quervain]-Other	0.002	0.998	0.000
M65.47 Radial styloid tenosynovitis [de Quervain]-Ankle/foot	0.002	0.998	0.000
M65.46 Radial styloid tenosynovitis [de Quervain]-Lower leg	0.002	0.998	0.000
M65.45 Radial styloid tenosynovitis [de Quervain]-Pelvic/thigh	0.002	0.998	0.000
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)	0.002	0.998	0.000
M65.42 Radial styloid tenosynovitis [de Quervain]-Upper arm	0.002	0.998	0.000
M65.41 Radial styloid tenosynovitis [de Quervain]-Shldr region	0.002	0.998	0.000
M65.40 Radial styloid tenosynovitis [de Quervain] (Multiple sites)	0.002	0.998	0.000
N97.1 Female infertility of tubal origin	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
D63 Anaemia in chronic diseases classified elsewhere	0.000	0.998	0.002
M21 Other acquired deformities of limbs	0.002	0.998	0.000
K82.8 Other specified diseases of gallbladder	0.000	0.998	0.002
Z91 Personal history of risk-factors, not elsewhere classified	0.000	0.998	0.002
M19.89 Other specified arthrosis (Site unspecified)	0.000	0.998	0.002
M19.88 Other specified arthrosis (Other)	0.000	0.998	0.002
M19.87 Other specified arthrosis (Ankle and foot)	0.000	0.998	0.002
M19.86 Other specified arthrosis (Lower leg)	0.000	0.998	0.002
M19.85 Other specified arthrosis (Pelvic region and thigh)	0.000	0.998	0.002
M19.84 Other specified arthrosis (Hand)	0.000	0.998	0.002
M19.83 Other specified arthrosis (Forearm)	0.000	0.998	0.002
M19.82 Other specified arthrosis (Upper arm)	0.000	0.998	0.002
M19.81 Other specified arthrosis (Shoulder region)	0.000	0.998	0.002
M19.80 Other specified arthrosis (Multiple sites)	0.000	0.998	0.002
S22.41 Multiple fractures of ribs (open)	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
M21.1 Varus deformity, not elsewhere classified	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.001
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.001
T38.7 Androgens and anabolic congeners	0.000	0.998	0.001
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.001
T38.5 Other oestrogens and progestogens	0.000	0.998	0.001
T38.4 Oral contraceptives	0.000	0.998	0.001
T38.2 Antithyroid drugs	0.000	0.998	0.001
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.001
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.001
M88 Paget's disease of bone [osteitis deformans]	0.002	0.998	0.000
S22.0 Fracture of thoracic vertebra	0.000	0.998	0.002
M21.16 Varus deformity, not elsewhere classified (Lower leg)	0.002	0.998	0.000
M21.4 Flat foot [pes planus] (acquired)	0.002	0.998	0.000
O82 Single delivery by Caesarean section	0.002	0.998	0.000
R20 Disturbances of skin sensation	0.000	0.998	0.002
M21.2 Flexion deformity	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.001
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
M19.01 Primary arthrosis of other joints (Shoulder region)	0.000	0.998	0.002
I61.9 Intracerebral haemorrhage, unspecified	0.002	0.998	0.000
O71.4 Obstetric high vaginal laceration alone	0.002	0.998	0.000
I63 Cerebral infarction	0.002	0.998	0.000
M21.47 Flat foot [pes planus] (acquired)-Ankle/foot	0.002	0.998	0.000
M19.19 Post-traumatic arthrosis of other joints (Site unspecified)	0.000	0.998	0.001
M19.18 Post-traumatic arthrosis of other joints (Other)	0.000	0.998	0.001
M19.16 Post-traumatic arthrosis of other joints-Lower leg	0.000	0.998	0.001
M19.15 Post-traumatic arthrosis of other joints (Pelvic region and thigh)	0.000	0.998	0.001
M19.14 Post-traumatic arthrosis of other joints (Hand)	0.000	0.998	0.001
M19.13 Post-traumatic arthrosis of other joints (Forearm)	0.000	0.998	0.001
M19.12 Post-traumatic arthrosis of other joints (Upper arm)	0.000	0.998	0.001
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.000	0.998	0.001
M19.10 Post-traumatic arthrosis of other joints (Multiple sites)	0.000	0.998	0.001
M19.29 Other secondary arthrosis (Site unspecified)	0.000	0.998	0.001
M19.28 Other secondary arthrosis (Other)	0.000	0.998	0.001
M19.26 Other secondary arthrosis of other joints-Lower leg	0.000	0.998	0.001
M19.25 Other secondary arthrosis (Pelvic region and thigh)	0.000	0.998	0.001
M19.24 Other secondary arthrosis (Hand)	0.000	0.998	0.001
M19.23 Other secondary arthrosis (Forearm)	0.000	0.998	0.001
M19.22 Other secondary arthrosis (Upper arm)	0.000	0.998	0.001
M19.21 Other secondary arthrosis (Shoulder region)	0.000	0.998	0.001
M19.20 Other secondary arthrosis (Multiple sites)	0.000	0.998	0.001
I51.9 Heart disease, unspecified	0.002	0.998	0.000
K65.8 Other peritonitis	0.000	0.998	0.001
S22 Fracture of rib(s), sternum and thoracic spine	0.000	0.998	0.002
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.002	0.998	0.000
M21.27 Flexion deformity (Ankle and foot)	0.002	0.998	0.000
K14.9 Disease of tongue, unspecified	0.000	0.998	0.002
M21.6 Other acquired deformities of ankle and foot	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
O68 Labour and delivery complicated by foetal stress [distress]	0.002	0.998	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.998	0.002
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.002	0.998	0.000
D63.1 Anaemia in other chronic diseases classified elsewhere	0.000	0.998	0.001
I67.8 Other specified cerebrovascular diseases	0.002	0.998	0.000
M21.9 Acquired deformity of limb, unspecified	0.002	0.998	0.000
M21.8 Other specified acquired deformities of limbs	0.002	0.998	0.000
M21.7 Unequal limb length (acquired)	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.001
Q61.0 Congenital single renal cyst	0.000	0.998	0.002
S42.20 Fracture of upper end of humerus (closed)	0.000	0.998	0.002
E10.5 With peripheral circulatory complications	0.002	0.998	0.000
R25.2 Cramp and spasm	0.002	0.998	0.000
Z91.8 Personal history of other specified risk-factors, not elsewhere classified	0.000	0.998	0.001
Z91.7 Personal history of female genital mutilation	0.000	0.998	0.001
Z91.4 Personal history of psychological trauma, not elsewhere classified	0.000	0.998	0.001
Z91.3 Personal history of unhealthy sleep-wake schedule	0.000	0.998	0.001
Z91.2 Personal history of poor personal hygiene	0.000	0.998	0.001
M21.19 Varus deformity, not elsewhere classified (Site unspecified)	0.001	0.998	0.000
M21.18 Varus deformity, not elsewhere classified (Other)	0.001	0.998	0.000
M21.15 Varus deformity, not elsewhere classified (Pelvic region and thigh)	0.001	0.998	0.000
M21.14 Varus deformity, not elsewhere classified (Hand)	0.001	0.998	0.000
M21.13 Varus deformity, not elsewhere classified (Forearm)	0.001	0.998	0.000
M21.12 Varus deformity, not elsewhere classified (Upper arm)	0.001	0.998	0.000
M21.11 Varus deformity, not elsewhere classified (Shoulder region)	0.001	0.998	0.000
M21.10 Varus deformity, not elsewhere classified (Multiple sites)	0.001	0.998	0.000
L98.4 Chronic ulcer of skin, not elsewhere classified	0.002	0.998	0.000
O82.1 Delivery by emergency Caesarean section	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.998	0.001
M21.17 Varus deformity, not elsewhere classified (Ankle and foot)	0.001	0.998	0.000
D72.8 Other specified disorders of white blood cells	0.000	0.998	0.002
M88.8 Paget's disease of other bones	0.001	0.998	0.000
M88.0 Paget's disease of skull	0.001	0.998	0.000
M21.49 Flat foot [pes planus] (acquired)-Site unspec	0.001	0.998	0.000
M21.48 Flat foot [pes planus] (acquired)-Other	0.001	0.998	0.000
M21.46 Flat foot [pes planus] (acquired)-Lower leg	0.001	0.998	0.000
M21.45 Flat foot [pes planus] (acquired)-Pelvic/thigh	0.001	0.998	0.000
M21.44 Flat foot [pes planus] (acquired)-Hand	0.001	0.998	0.000
M21.43 Flat foot [pes planus] (acquired)-Forearm	0.001	0.998	0.000
M21.42 Flat foot [pes planus] (acquired)-Upper arm	0.001	0.998	0.000
M21.41 Flat foot [pes planus] (acquired)-Shldr region	0.001	0.998	0.000
M21.40 Flat foot [pes planus] (acquired)-Mult sites	0.001	0.998	0.000
S22.01 Fracture of thoracic vertebra (open)	0.000	0.998	0.001
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.998	0.002
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.002	0.998	0.000
M19.0 Primary arthrosis of other joints	0.000	0.998	0.001
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot	0.001	0.998	0.000
M21.0 Valgus deformity, not elsewhere classified	0.001	0.998	0.000
O82.8 Other single delivery by Caesarean section	0.001	0.998	0.000
O82.2 Delivery by Caesarean hysterectomy	0.001	0.998	0.000
R20.1 Hypoaesthesia of skin	0.000	0.998	0.001
R20.0 Anaesthesia of skin	0.000	0.998	0.001
S27.0 Traumatic pneumothorax	0.000	0.998	0.001
Q61 Cystic kidney disease	0.000	0.998	0.002
M21.29 Flexion deformity (Site unspecified)	0.001	0.998	0.000
M21.28 Flexion deformity (Other)	0.001	0.998	0.000
M21.26 Flexion deformity (Lower leg)	0.001	0.998	0.000
M21.25 Flexion deformity (Pelvic region and thigh)	0.001	0.998	0.000
M21.24 Flexion deformity (Hand)	0.001	0.998	0.000
M21.23 Flexion deformity (Forearm)	0.001	0.998	0.000
M21.22 Flexion deformity (Upper arm)	0.001	0.998	0.000
M21.21 Flexion deformity (Shoulder region)	0.001	0.998	0.000
M21.20 Flexion deformity (Multiple sites)	0.001	0.998	0.000
M87.20 Osteonecrosis due to previous trauma (Multiple sites)	0.001	0.998	0.000
T51.0 Ethanol	0.000	0.998	0.002
E10.3 With ophthalmic complications	0.002	0.998	0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.001	0.998	0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.001	0.998	0.000
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.001	0.998	0.000
L98.0 Pyogenic granuloma	0.001	0.998	0.000
O81.4 Vacuum extractor delivery	0.001	0.998	0.000
O82.9 Delivery by Caesarean section, unspecified	0.001	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.001
T40.8 Lysergide [LSD]	0.000	0.998	0.001
T40.7 Cannabis (derivatives)	0.000	0.998	0.001
T40.5 Cocaine	0.000	0.998	0.001
T40.3 Methadone	0.000	0.998	0.001
T40.1 Heroin	0.000	0.998	0.001
T40.0 Opium	0.000	0.998	0.001
Z91.5 Personal history of self-harm	0.000	0.998	0.002
M19.27 Other secondary arthrosis (Ankle and foot)	0.000	0.998	0.001
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.001	0.998	0.000
O80.9 Single spontaneous delivery, unspecified	0.002	0.998	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.001	0.998	0.000
M21.67 Other acquired deformities of ankle and foot-Ankle/foot	0.001	0.998	0.000
O73.0 Retained placenta, without haemorrhage	0.001	0.998	0.000
O75.8 Other specified complications of labour and delivery	0.001	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.001
S27 Injury of other and unspecified intrathoracic organs	0.000	0.998	0.001
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.000	0.998	0.001
E10.4 With neurological complications	0.001	0.998	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.001	0.998	0.000
L98.7 Excessive and redundant skin and subcutaneous tissue	0.001	0.998	0.000
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.001	0.998	0.000
L98.5 Mucinosis of skin	0.001	0.998	0.000
L98.3 Eosinophilic cellulitis [Wells]	0.001	0.998	0.000
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.001	0.998	0.000
L98.1 Factitial dermatitis	0.001	0.998	0.000
O86.4 Pyrexia of unknown origin following delivery	0.001	0.998	0.000
S22.9 Fracture of bony thorax, part unspecified	0.000	0.998	0.001
S22.8 Fracture of other parts of bony thorax	0.000	0.998	0.001
S22.5 Flail chest	0.000	0.998	0.001
M21.69 Other acquired deformities of ankle and foot-Site unspec	0.001	0.999	0.000
M21.68 Other acquired deformities of ankle and foot-Other	0.001	0.999	0.000
M21.66 Other acquired deformities of ankle and foot-Lower leg	0.001	0.999	0.000
M21.65 Other acquired deformities of ankle and foot-Pelvic/thigh	0.001	0.999	0.000
M21.64 Other acquired deformities of ankle and foot-Hand	0.001	0.999	0.000
M21.63 Other acquired deformities of ankle and foot-Forearm	0.001	0.999	0.000
M21.62 Other acquired deformities of ankle and foot-Upper arm	0.001	0.999	0.000
M21.61 Other acquired deformities of ankle and foot-Shldr region	0.001	0.999	0.000
M21.60 Other acquired deformities of ankle and foot-Mult sites	0.001	0.999	0.000
M47.92 Spondylosis, unspecified (Cervical region)	0.001	0.999	0.000
M35.3 Polymyalgia rheumatica	0.001	0.999	0.000
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.001	0.999	0.000
M21.79 Unequal limb length (acquired) (Site unspecified)	0.001	0.999	0.000
M21.78 Unequal limb length (acquired)-Other	0.001	0.999	0.000
M21.77 Unequal limb length (acquired) (Ankle and foot)	0.001	0.999	0.000
M21.76 Unequal limb length (acquired) (Lower leg)	0.001	0.999	0.000
M21.75 Unequal limb length (acquired) (Pelvic region and thigh)	0.001	0.999	0.000
M21.74 Unequal limb length (acquired) (Hand)	0.001	0.999	0.000
M21.73 Unequal limb length (acquired) (Forearm)	0.001	0.999	0.000
M21.72 Unequal limb length (acquired) (Upper arm)	0.001	0.999	0.000
M21.71 Unequal limb length (acquired)-Shldr region	0.001	0.999	0.000
M21.70 Unequal limb length (acquired) (Multiple sites)	0.001	0.999	0.000
M21.89 Other specified acquired deformities of limbs (Site unspecified)	0.001	0.999	0.000
M21.88 Other specified acquired deformities of limbs-Other	0.001	0.999	0.000
M21.87 Other specified acquired deformities of limbs (Ankle and foot)	0.001	0.999	0.000
M21.86 Other specified acquired deformities of limbs (Lower leg)	0.001	0.999	0.000
M21.85 Other specified acquired deformities of limbs (Pelvic region and thigh)	0.001	0.999	0.000
M21.84 Other specified acquired deformities of limbs (Hand)	0.001	0.999	0.000
M21.83 Other specified acquired deformities of limbs (Forearm)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations